Fenofibrate Tablet
Product Images NDC 69097-459

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Fenofibrate (NDC 69097-459). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cipla Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 01

Chemical structure diagram of Fenofibrate, showing the molecular arrangement including aromatic rings, carbonyl groups, and chlorophenyl components.*

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 02

Fenofibrate Tablets USP 48 mg oral tablets packaging label for a 30-tablet bottle by Cipla USA Inc. The label includes dosage strength, quantity, manufacturer information, storage instructions, a barcode, and a QR code area for batch overprinting with serial number, expiry, and lot details.*

FDA Label Image

5793281e 4b4f 44a1 9edd Fc4b2d4630e3 03

Fenofibrate Tablets USP 145 mg oral tablet label showing package size of 30 tablets. The label includes storage instructions and warnings, manufactured by Cipla Ltd., India, for Cipla USA Inc., Warren, NJ. Barcode and NDC 69097-458-02 are visible on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.